Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke
Background and Purpose In a recent pooled analysis of randomized clinical trials (RCTs), intravenous tissue plasminogen activator (TPA) improves the outcome in patients aged ≥80 years. However, it is uncertain whether the findings are applicable to clinical practice in Asian populations. Methods Fro...
Main Authors: | Jay Chol Choi, Ji Sung Lee, Tai Hwan Park, Sang-Soon Park, Yong-Jin Cho, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Soo-Joo Lee, Youngchai Ko, Jae Guk Kim, Jun Lee, Ki-Hyun Cho, Joon-Tae Kim, Kyung-Ho Yu, Byung-Chul Lee, Mi-Sun Oh, Jae-Kwan Cha, Dae-Hyun Kim, Hyun-Wook Nah, Dong-Eog Kim, Wi-Sun Ryu, Beom Joon Kim, Hee-Joon Bae, Wook-Joo Kim, Dong-Ick Shin, Min-Ju Yeo, Sung Il Sohn, Jeong-Ho Hong, Juneyoung Lee, Keun-Sik Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Stroke Society
2015-09-01
|
Series: | Journal of Stroke |
Subjects: | |
Online Access: | http://www.j-stroke.org/upload/pdf/jos-17-3-327.pdf |
Similar Items
-
Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis
by: Jay Chol Choi, et al.
Published: (2016-09-01) -
Case Characteristics, Hyperacute Treatment, and Outcome Information from the Clinical Research Center for Stroke-Fifth Division Registry in South Korea
by: Beom Joon Kim, et al.
Published: (2015-01-01) -
ERRATUM: Table Correction: Case Characteristics, Hyperacute Treatment, and Outcome Information from the Clinical Research Center for Stroke-Fifth Division Registry in South Korea
by: Beom Joon Kim, et al.
Published: (2015-09-01) -
Nationwide Estimation of Eligibility for Endovascular Thrombectomy Based on the DAWN Trial
by: Keon-Joo Lee, et al.
Published: (2018-05-01) -
Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke
by: Joon-Tae Kim, et al.